Drug recall · February 4, 2026
INON ACE Antacid tablets recall
Why: Failed Disintegration Specifications: above the time expected.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
- Lots / codes
Lot#: PWXT, Exp 1/31/2027
- Quantity
- 3,640 bottles
- Company
- Sato Pharmaceutical Co., Ltd, Tokyo, N/A
- Distribution
- CA and HI
- Initiated
- December 19, 2025 · Voluntary: Firm initiated
- Classified
- January 27, 2026
- Reported
- February 4, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Simethicone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.